Matches in SemOpenAlex for { <https://semopenalex.org/work/W2512895854> ?p ?o ?g. }
- W2512895854 endingPage "839" @default.
- W2512895854 startingPage "829" @default.
- W2512895854 abstract "BackgroundStatin therapy is effective for the prevention of coronary heart disease and stroke in patients with mild-to-moderate chronic kidney disease, but its effects in individuals with more advanced disease, particularly those undergoing dialysis, are uncertain.MethodsWe did a meta-analysis of individual participant data from 28 trials (n=183 419), examining effects of statin-based therapy on major vascular events (major coronary event [non-fatal myocardial infarction or coronary death], stroke, or coronary revascularisation) and cause-specific mortality. Participants were subdivided into categories of estimated glomerular filtration rate (eGFR) at baseline. Treatment effects were estimated with rate ratio (RR) per mmol/L reduction in LDL cholesterol.FindingsOverall, statin-based therapy reduced the risk of a first major vascular event by 21% (RR 0·79, 95% CI 0·77–0·81; p<0·0001) per mmol/L reduction in LDL cholesterol. Smaller relative effects on major vascular events were observed as eGFR declined (p=0·008 for trend; RR 0·78, 99% CI 0·75–0·82 for eGFR ≥60 mL/min per 1·73 m2; 0·76, 0·70–0·81 for eGFR 45 to <60 mL/min per 1·73 m2; 0·85, 0·75–0·96 for eGFR 30 to <45 mL/min per 1·73 m2; 0·85, 0·71–1·02 for eGFR <30 mL/min per 1·73 m2 and not on dialysis; and 0·94, 0·79–1·11 for patients on dialysis). Analogous trends by baseline renal function were seen for major coronary events (p=0·01 for trend) and vascular mortality (p=0·03 for trend), but there was no significant trend for coronary revascularisation (p=0·90). Reducing LDL cholesterol with statin-based therapy had no effect on non-vascular mortality, irrespective of eGFR.InterpretationEven after allowing for the smaller reductions in LDL cholesterol achieved by patients with more advanced chronic kidney disease, and for differences in outcome definitions between dialysis trials, the relative reductions in major vascular events observed with statin-based treatment became smaller as eGFR declined, with little evidence of benefit in patients on dialysis. In patients with chronic kidney disease, statin-based regimens should be chosen to maximise the absolute reduction in LDL cholesterol to achieve the largest treatment benefits.FundingUK Medical Research Council, British Heart Foundation, Cancer Research UK, European Community Biomed Programme, Australian National Health and Medical Research Council, Australian National Heart Foundation." @default.
- W2512895854 created "2016-09-16" @default.
- W2512895854 creator A5011540823 @default.
- W2512895854 creator A5011948462 @default.
- W2512895854 creator A5013453825 @default.
- W2512895854 creator A5018014320 @default.
- W2512895854 creator A5030243760 @default.
- W2512895854 creator A5030250235 @default.
- W2512895854 creator A5033368647 @default.
- W2512895854 creator A5042828582 @default.
- W2512895854 creator A5065348937 @default.
- W2512895854 creator A5071483338 @default.
- W2512895854 creator A5071642919 @default.
- W2512895854 creator A5071903285 @default.
- W2512895854 creator A5077916068 @default.
- W2512895854 creator A5078477384 @default.
- W2512895854 creator A5079926383 @default.
- W2512895854 creator A5088849387 @default.
- W2512895854 creator A5088900128 @default.
- W2512895854 creator A5090621185 @default.
- W2512895854 date "2016-10-01" @default.
- W2512895854 modified "2023-10-14" @default.
- W2512895854 title "Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials" @default.
- W2512895854 cites W137344628 @default.
- W2512895854 cites W1523152575 @default.
- W2512895854 cites W1546258268 @default.
- W2512895854 cites W1583447426 @default.
- W2512895854 cites W1604547439 @default.
- W2512895854 cites W1667887382 @default.
- W2512895854 cites W1872963730 @default.
- W2512895854 cites W1922547794 @default.
- W2512895854 cites W1967903948 @default.
- W2512895854 cites W1967917591 @default.
- W2512895854 cites W2004511808 @default.
- W2512895854 cites W2004904080 @default.
- W2512895854 cites W2018711158 @default.
- W2512895854 cites W2020274264 @default.
- W2512895854 cites W2031185570 @default.
- W2512895854 cites W2036961560 @default.
- W2512895854 cites W2048453237 @default.
- W2512895854 cites W2049893341 @default.
- W2512895854 cites W2064446331 @default.
- W2512895854 cites W2085731897 @default.
- W2512895854 cites W2087521717 @default.
- W2512895854 cites W2096537254 @default.
- W2512895854 cites W2100800328 @default.
- W2512895854 cites W2107295258 @default.
- W2512895854 cites W2110601215 @default.
- W2512895854 cites W2111663222 @default.
- W2512895854 cites W2111963345 @default.
- W2512895854 cites W2116045728 @default.
- W2512895854 cites W2118184073 @default.
- W2512895854 cites W2118667643 @default.
- W2512895854 cites W2126452437 @default.
- W2512895854 cites W2126563293 @default.
- W2512895854 cites W2126678006 @default.
- W2512895854 cites W2129750583 @default.
- W2512895854 cites W2130636082 @default.
- W2512895854 cites W2132117066 @default.
- W2512895854 cites W2134120087 @default.
- W2512895854 cites W2135631433 @default.
- W2512895854 cites W2136057035 @default.
- W2512895854 cites W2137983259 @default.
- W2512895854 cites W2139168645 @default.
- W2512895854 cites W2139664471 @default.
- W2512895854 cites W2155598961 @default.
- W2512895854 cites W2155965977 @default.
- W2512895854 cites W2156711209 @default.
- W2512895854 cites W2156880046 @default.
- W2512895854 cites W2159449551 @default.
- W2512895854 cites W2160986394 @default.
- W2512895854 cites W2162430779 @default.
- W2512895854 cites W2164089346 @default.
- W2512895854 cites W2165692718 @default.
- W2512895854 cites W2167045683 @default.
- W2512895854 cites W2247997571 @default.
- W2512895854 cites W2287366392 @default.
- W2512895854 cites W2322095705 @default.
- W2512895854 cites W2463307031 @default.
- W2512895854 cites W38523360 @default.
- W2512895854 cites W424467158 @default.
- W2512895854 doi "https://doi.org/10.1016/s2213-8587(16)30156-5" @default.
- W2512895854 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27477773" @default.
- W2512895854 hasPublicationYear "2016" @default.
- W2512895854 type Work @default.
- W2512895854 sameAs 2512895854 @default.
- W2512895854 citedByCount "219" @default.
- W2512895854 countsByYear W25128958542016 @default.
- W2512895854 countsByYear W25128958542017 @default.
- W2512895854 countsByYear W25128958542018 @default.
- W2512895854 countsByYear W25128958542019 @default.
- W2512895854 countsByYear W25128958542020 @default.
- W2512895854 countsByYear W25128958542021 @default.
- W2512895854 countsByYear W25128958542022 @default.
- W2512895854 countsByYear W25128958542023 @default.
- W2512895854 crossrefType "journal-article" @default.
- W2512895854 hasAuthorship W2512895854A5011540823 @default.
- W2512895854 hasAuthorship W2512895854A5011948462 @default.